Regeneron Pharmaceuticals | 10-Q: Quarterly report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports First Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer YANCOPOULOS GEORGE
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer YANCOPOULOS GEORGE
Regeneron Pharmaceuticals | ARS: Annual Report to Security Holders
Regeneron Pharmaceuticals | DEFA14A: Others
Regeneron Pharmaceuticals | DEF 14A: Definitive information statements
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer McCourt Marion
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MURPHY ANDREW J
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer McCourt Marion
Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LAROSA JOSEPH J
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SING GEORGE L
Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer STAHL NEIL
No Data